Adult Pneumococcal Vaccinations Could Increase Under CDC Program

The Centers for Disease Control & Prevention is awarding a two-year contract to evaluate whether a proactive pharmacist pneumococcal vaccination program would increase adult use of the vaccine. Merck’s Pneumovax 23 is the only pneumococcal vaccine commercially available for adults.